Halozyme Therapeutics (HALO) Acquisitions (2026)
Halozyme Therapeutics' (HALO) quarterly Acquisitions came in at $710000.0 in Q1 2026.
Halozyme Therapeutics (HALO) Acquisitions (2026) Analysis & Trends
Halozyme Therapeutics (HALO) has 1 years of Acquisitions data on file, last reported at $710000.0 in Q1 2026.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $710000.0 in Q1 2026; TTM through Mar 2026 was $710000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $726.0 million, changed N/A from the prior year.
- Acquisitions for Q1 2026 stood at $710000.0.
- Over the last five years, Acquisitions for HALO reached as high as $710000.0 in Q1 2026 and fell as low as $710000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Halozyme Therapeutics | 9.55 Bn | 9.23 Bn | 297.47 Mn | 710,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 710,000.00 |